Adrian Diaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adrian Diaz has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Gilda Cardenosa
Department of Radiology, Virginia Commonwealth University, Richmond, VA, USA
1 shared publication- Harry Douglas Bear
Division of Surgical Oncology, Department of Surgery and the Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA
1 shared publication - Kellie J. Archer
Division of Biostatistics College of Public Health, The Ohio State University Columbus Ohio USA
1 shared publication Rebecca R. Lehman
Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, USA
1 shared publicationSidrah Khan
Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA
1 shared publicationTiffany Mullins
Department of Pathology, Virginia Commonwealth University, Richmond, VA, USA
1 shared publication
Latest Publications
- 27 August 2017
- Published by Wiley in The Breast Journal
- Vol. 24 (3) , 350-355
Papillary lesions of the breast: To excise or observe?
Papillary lesions of the breast range from benign to atypical to malignant. Although papillomas without frank cancer are benign, their management remains controversial. When a core needle biopsy of a lesion yields a diagnosis of intraductal papilloma with atypia, excision is generally recommended to rule out a concurrent malignant neoplasm. For intraductal papillomas without atypia, however, recommendations for excision versus observation are variable. The aims of this study are to evaluate the rate of concurrent malignancies for intraductal papilloma diagnosed on core needle biopsy and to assess the long-term risk of developing cancer after the diagnosis of a papillary lesion. This single institution retrospective study analyzed 259 patients that were diagnosed with intraductal papilloma (IDP) by core needle biopsy from 1995 to 2010. Patients were grouped by initial diagnosis into three groups (papilloma without atypia, papilloma with atypia, and papilloma with atypical duct hyperplasia or atypical lobular hyperplasia (ADH/ALH) and followed up for long-term outcomes. After a core needle biopsy showing IDP with atypia or IDP + ADH/ALH, surgical excision yielded a diagnosis of concomitant invasive or ductal in situ cancer in greater that 30% of cases. For intraductal papilloma without atypia, the likelihood of cancer was much lower. Moreover, even with excision, the finding of intraductal papilloma with atypia carries a significant risk of developing cancer long-term, and such patients should be followed carefully and perhaps should be considered for chemoprevention.
- 27 August 2017
- Published by Wiley in The Breast Journal
- Vol. 24 (3) , 350-355
Papillary lesions of the breast: To excise or observe?
Papillary lesions of the breast range from benign to atypical to malignant. Although papillomas without frank cancer are benign, their management remains controversial. When a core needle biopsy of a lesion yields a diagnosis of intraductal papilloma with atypia, excision is generally recommended to rule out a concurrent malignant neoplasm. For intraductal papillomas without atypia, however, recommendations for excision versus observation are variable. The aims of this study are to evaluate the rate of concurrent malignancies for intraductal papilloma diagnosed on core needle biopsy and to assess the long-term risk of developing cancer after the diagnosis of a papillary lesion. This single institution retrospective study analyzed 259 patients that were diagnosed with intraductal papilloma (IDP) by core needle biopsy from 1995 to 2010. Patients were grouped by initial diagnosis into three groups (papilloma without atypia, papilloma with atypia, and papilloma with atypical duct hyperplasia or atypical lobular hyperplasia (ADH/ALH) and followed up for long-term outcomes. After a core needle biopsy showing IDP with atypia or IDP + ADH/ALH, surgical excision yielded a diagnosis of concomitant invasive or ductal in situ cancer in greater that 30% of cases. For intraductal papilloma without atypia, the likelihood of cancer was much lower. Moreover, even with excision, the finding of intraductal papilloma with atypia carries a significant risk of developing cancer long-term, and such patients should be followed carefully and perhaps should be considered for chemoprevention.